5.01
price up icon2.04%   0.10
after-market Handel nachbörslich: 5.00 -0.010 -0.20%
loading

Finanzdaten der Evolus Inc-Aktie (EOLS)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
30.93%
90.30
68.97 69.39 68.52 78.95
Cost Of Revenue
34.09%
31.01
23.13 24.07 21.87 28.60
Gross Profit
29.34%
59.29
45.84 45.32 46.66 50.34
Operating Expenses
3.96%
55.07
57.34 55.53 61.83 52.66
Benefits Costs and Expenses
6.21%
89.78
84.54 86.48 87.34 85.30
Costs And Expenses
3.96%
55.07
57.34 55.53 61.83 -2.709
Depreciation and Amortization
26.51%
1.446
1.143 0.932 0.824 -
Operating Income/Loss
136.70%
4.22
-11.50 -10.21 -15.17 -2.314
Income/Loss From Continuing Operations Before Tax
103.31%
0.515
-15.57 -17.09 -18.82 -6.351
Income Tax Expense/Benefit, Deferred
228.57%
0.027
-0.021 0.02 -0.005 -0.023
Income Tax Expense/Benefit
130.54%
0.385
0.167 0.053 0.072 0.44
Income/Loss From Continuing Operations After Tax
100.83%
0.13
-15.74 -17.14 -18.89 -6.791
Net Income/Loss
100.83%
0.13
-15.74 -17.14 -18.89 -6.791
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
99.78%
0.1444
64.73 64.54 63.70 0.4541
Diluted Average Shares
99.78%
0.1444
64.73 64.54 63.70 0.4541
Basic Earnings Per Share
100.00%
-
-0.24 -0.27 -0.30 -0.10
Diluted Earnings Per Share
100.00%
-
-0.24 -0.27 -0.30 -0.10
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$22.94
price up icon 1.15%
drug_manufacturers_specialty_generic RGC
$23.23
price down icon 3.21%
drug_manufacturers_specialty_generic RDY
$14.13
price down icon 1.53%
$129.78
price up icon 1.57%
$13.51
price down icon 2.10%
$536.12
price up icon 0.62%
Kapitalisierung:     |  Volumen (24h):